SCHEMBL2380903

SCHEMBL2380903

CCCCCN(N)[C@@H](CCC(=O)ON)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOD1 Q9Y239 2/20 0.40
SLC1A1 P43005 3/20 0.36
GRIK1 P39086 2/20 0.36
GRIK2 Q13002 2/20 0.36
SLC1A2 P43004 2/20 0.36
GPR84 Q9NQS5 3/20 0.34
FFAR1 O14842 1/20 0.34
SLC1A3 P43003 1/20 0.34
MAPT P10636 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
LCK P06239 1/20 0.33
PPARD Q03181 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.33
ZDHHC2 Q9UIJ5 1/20 0.33
DNM1 Q05193 2/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8019482 0.84 AKR1B1 (0.44) NOD1GPR84FFAR1MEN1KMT2A
SCHEMBL5495885 0.83 NOD1 (0.42) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL5495880 0.83 NOD1 (0.42) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL11305652 0.78 GRIK1 (0.40) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL11308884 0.77 GRIK1 (0.42) SLC1A1GRIK1GRIK2SLC1A2GPR84
SCHEMBL28182375 0.76 GRIK1 (0.40) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL6860131 0.74 GRIK1 (0.49) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL8025770 0.74 GPR84 (0.42) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL28120701 0.74 GRIK1 (0.39) NOD1SLC1A1GRIK1GRIK2SLC1A2
SCHEMBL28078461 0.74 AKR1B1 (0.42) GPR84FFAR1MEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105050574-B Transparent compositions comprising non-polymeric organogelators 莱雅公司 2019-05-31 CN claimed
EP-2544654-A2 DUAL FUNCTION PRODUCT L'Oréal (FR) 2013-01-16 EP claimed
WO-2011112801-A2 DUAL FUNCTION PRODUCT L'OREAL (FR) 2011-09-15 WO claimed
WO-2011112804-A2 LONG-WEARING NON-AQUEOUS STRUCTURED COLOR COSMETIC L'OREAL (FR) 2011-09-15 WO claimed
CN-110225741-A Solid water-in-oil cosmetic emulsions 香奈儿香水美妆品公司 2019-09-10 CN disclosed
CN-110200817-A Cosmetic composition 莱雅公司 2019-09-06 CN disclosed
CN-110101606-A Liquid cosmetic composition 莱雅公司 2019-08-09 CN disclosed
CN-110087608-A Solic cosmetic composition with moistening effect 香奈儿香水美妆品公司 2019-08-02 CN disclosed
CN-105050574-B Transparent compositions comprising non-polymeric organogelators 莱雅公司 2019-05-31 CN disclosed
CN-104394832-B Include the cosmetic composition of oil, hydrophobic silicon dioxide aerogel particle and hydrocarbon-based resins 莱雅公司 2018-05-08 CN disclosed
CN-101365415-B Gelling agent AJINOMOTO KK 2012-09-12 CN disclosed
CN-101365415-A Gelling agent AJINOMOTO KK (JP) 2009-02-11 CN disclosed
EP-1315474-A2 CLEAR ANTIPERSPIRANTS AND DEODORANTS MADE WITH SILOXANE-BASED POLYAMIDES Colgate-Palmolive Company (US) 2003-06-04 EP disclosed
US-6451295-B1 SILICONIZED POLYAMIDE FORMULATED WITH AT LEAST ONE SILICONE MATERIAL AND AT LEAST ONE NON-SILICONE EMOLLIENT; CLEAR PRODUCTS WITH IMPROVED STRUCTURAL STABILITY AND INTEGRITY COLGATE-PALMOLIVE COMPANY 2002-09-17 US disclosed
US-20020051758-A1 Clear antiperspirants and deodorants made with siloxane-based polyamides DOW SILICONES CORPORATION 2002-05-02 US disclosed
WO-2002017870-A2 CLEAR ANTIPERSPIRANTS AND DEODORANTS MADE WITH SILOXANE-BASED POLYAMIDES COLGATE-PALMOLIVE COMPANY (US) 2002-03-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020051758-A1 Clear antiperspirants and deodorants made with siloxane-based polyamides TAS2R42, DDT, QDPR NOD1 4858/4885SLC1A1 1126/4885GRIK1 2739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.